Option Care Health (NASDAQ:OPCH) Downgraded to “Hold” Rating by Stephens

Stephens cut shares of Option Care Health (NASDAQ:OPCH) from a strong-buy rating to a hold rating in a report published on Friday,Zacks.com reports.

Other equities research analysts also recently issued reports about the stock. UBS Group reiterated a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 target price on the stock. in a report on Friday, May 1st. Weiss Ratings downgraded Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $26.00 target price on shares of Option Care Health in a research report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $30.08.

Option Care Health Stock Performance

Option Care Health stock opened at $21.74 on Friday. The stock’s 50-day moving average is $21.15 and its 200-day moving average is $27.50. The company has a market cap of $3.41 billion, a price-to-earnings ratio of 16.85, a price-to-earnings-growth ratio of 1.23 and a beta of 0.65. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts anticipate that Option Care Health will post 1.64 earnings per share for the current year.

Insider Activity

In other Option Care Health news, CEO John Charles Rademacher bought 12,500 shares of the stock in a transaction dated Monday, May 4th. The stock was bought at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the transaction, the director owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. The trade was a 8.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 73,264 shares of company stock worth $1,548,316 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently bought and sold shares of OPCH. Wedge Capital Management L L P NC raised its position in shares of Option Care Health by 25.7% in the 2nd quarter. Wedge Capital Management L L P NC now owns 190,257 shares of the company’s stock valued at $3,990,000 after purchasing an additional 38,856 shares in the last quarter. Harbor Investment Advisory LLC acquired a new stake in shares of Option Care Health during the second quarter worth approximately $48,000. Central Pacific Bank Trust Division increased its stake in shares of Option Care Health by 18.9% in the second quarter. Central Pacific Bank Trust Division now owns 13,829 shares of the company’s stock worth $290,000 after buying an additional 2,200 shares during the last quarter. Pacer Advisors Inc. increased its stake in shares of Option Care Health by 1.3% in the first quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after buying an additional 528 shares during the last quarter. Finally, Summitry LLC acquired a new stake in Option Care Health in the first quarter valued at $200,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.